Transcatheter Heart Valve Replacement Market size to exceed $10.5 Bn by 2025

Transcatheter Heart Valve Replacement Market size is set to exceed USD 10.5 billion by 2025; according to a new research study published by Global Market Insights, Inc.
 

Rising capital investment for the transcatheter heart valve devices by major market players is one of the primary factors augmenting the growth of the transcatheter heart valve replacement market in North America and Europe. For instance, Abbott laboratories; a global healthcare leader announced its investment in manufacturing of Portico transcatheter valve. Hence, venture capital investment in the production of transcatheter heart valve devices by major players in the healthcare sector will be a market driver in North America and Europe.

 

Request Sample Buy NowInquiry Before Buying

 

Valvular diseases are an emerging epidemic in most of the Asia Pacific countries. The prevalence of cardiac diseases is considerably high in China and India and has increased gradually over the past few years. Also, there is rise in quality of treatment offered to the patients. The enhancements in the valvular disease care and increasing awareness related to the transcatheter heart valve replacement devices may lead to boosting the business growth.
 

U.S. transcatheter heart valve replacement market, by product, 2018 & 2025 (USD Million)
Transcatheter Heart Valve Replacement Market

Get more details on this report - Request Free Sample PDF
 

Lack of awareness among the people in the Middle East and Africa region about the latest medical facilities is the primary drawback in the growth of the transcatheter heart valve replacement market. Most countries in the MEA region spend more on defense than on research and development and healthcare. Hence, healthcare industry in few of the MEA regions are lagging behind on primary indices of development
 

Browse key industry insights spread across 350 pages with 710 market data tables & 12 figures & charts from the report, “Transcatheter Heart Valves Market Size By Product (Transcatheter Aortic Valve, Transcatheter Mitral Valve {Mitral Valve Repair, Mitral Valve Replacement}, Transcatheter Pulmonary Valve), By Surgical Approach (Transfemoral Approach, Transapical Approach, Transaortic Approach), By Application (Aortic Valvular Heart Disease {Aortic Valve Stenosis, Aortic Valve Regurgitation}, Mitral Valvular Heart Disease {Mitral Valve Stenosis, Mitral Valve Regurgitation}, Pulmonary Valvular Heart Disease) By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Austria, Belgium, Czech Republic, Denmark, Finland, Greece, Ireland, Norway, Poland, Portugal, Sweden, Switzerland, Netherlands, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Israel), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/transcatheter-heart-valve-replacement-market

 

Transcatheter pulmonary valve replacement market was valued around USD 471.3 million in the year 2018. Increase in number of patients with narrowed or leaky pulmonary valve, specifically after surgical replacements are advised with transcatheter pulmonary valve replacement procedures. Hence, increase in pulmonary valvular disease will augment the growth of transcatheter heart valve replacement market in the future.
 

Transapical approach market is estimated to grow at a CAGR of 14.1% over the projection period. This approach is specifically used for the valve-in-valve implantation in mitral bio prosthesis and valve in ring implantation in annuloplasty rings for patients suffering from acute mitral regurgitation. Rise in prevalence of mitral valvular disease will enhance the growth of transcatheter heart valve replacement market in the upcoming years.
 

Application of transcatheter heart valve in pulmonary valvular heart disease was valued around USD 294.2 million in the year 2018. Increase in prevalence of pulmonary heart valvular disease among the neonates will be a major market driving factor.
 

The use of transcatheter heart valve in ambulatory surgical centers is estimated to grow at 14.1% over the forecast period. The ambulatory surgical centers are healthcare facilities that perform minimally invasive surgeries and that does not require hospitalization of the patient for a long time. Hence, increase in demand for minimally invasive surgeries in the ambulatory surgical centers will augment the business growth.
 

Germany dominated the Europe transcatheter heart valve replacement market and was valued around USD 348.1 million in the year 2018. Germany has been among the prominent nations accosts the globe in carrying out heart valve implantation procedures. Tremendous evolution in the past few years in transcatheter heart valve replacement in the country has resulted in growing demand and rapid adoption of the device, fueling the business growth.
 

Some of the key industry players operating in global neonatal ventilator market are Medtronic Plc, Edwards Lifesciences, Boston Scientific, Abbott. The industry player are majorly focusing on new product developments, new product launches, mergers and acquisitions and geographical expansion in order to increase their foothold in the market and gain competitive advantage.
 

Inquiry Before BuyingRequest Sample
 

Transcatheter heart valve replacement market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

Transcatheter Heart Valve Replacement Market by Product

  • Transcatheter aortic valve replacement
  • Transcatheter mitral valve
    • Mitral valve repair
    • Mitral valve replacement
  • Transcatheter pulmonary valve replacement

Transcatheter Heart Valve Replacement Market by Surgical Approach

  • Transfemoral approach
  • Transapical approach
  • Transaortic approach
  • Others

Transcatheter Heart Valve Replacement Market by Application

  • Aortic valvular heart disease
    • Aortic valve stenosis
    • Aortic valve regurgitation
  • Mitral valvular heart disease
    • Mitral valve stenosis
    • Mitral valve regurgitation
  • Pulmonary valvular heart disease

Transcatheter Heart Valve Replacement Market by End-use

  • Hospitals
  • Ambulatory surgical centers
  • Cardiac centers
  • Others

The above information is provided for the following regions/countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Austria
    • Belgium
    • Czech Republic
    • Denmark
    • Finland
    • Greece
    • Ireland
    • Norway
    • Poland
    • Portugal
    • Sweden
    • Switzerland
    • Netherlands
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X